AL-LAD (6-Allyl-6-nor-LSD)
A lysergamide similar to LSD but with a shorter duration and reportedly fewer anxious "head" effects, making it a popular research analog.
How it works
Activates serotonin 5-HT2A receptors, like LSD.
Key facts
- Molecular weight: 349.47 g/mol
- Half-life: ~3-4 hours
- Bioavailability: Oral
- Storage: Research/reference only.
Dosing overview
- Typical dose: Varies by individual and setting
- Frequency: Occasional
- Duration: Acute effects last 6-8 hours
- Route: Oral
Protocol notes
- Taken orally on blotter; shorter than LSD (6-8 hours) so easier to fit in a day.
- Reported to be more visual and less anxious than LSD.
Reported benefits
- Shorter than LSD
- Reportedly less anxious
- Strong visual component
- Lysergamide research compound
Possible side effects
- Anxiety
- Raised heart rate
- Visual distortions
- Limited human data
Compare AL-LAD
Research and educational reference only. Not medical advice.